Posts by ericg
9 Mass. college presidents made $1 million or more last year
Nine Massachusetts college campus leaders made $1 million or more in fiscal 2022 — and one nearly reached $3 million. Here are the 20 highest-paid college presidents in the Bay State. Read More
Read MoreAs patience wears thin, this year’s business bankruptcies have already surpassed 2023
The number of business bankruptcies in Massachusetts in the nine-month period ending on Sept. 30 has officially surpassed all of the business bankruptcies in 2022. Read More
Read MoreAs patience wears thin, this year’s business bankruptcies have already surpassed last year
The number of business bankruptcies in Massachusetts in the nine-month period ending on Sept. 30 has officially surpassed all of the business bankruptcies in 2022. Read More
Read MoreWhoop hit by class-action lawsuit over auto-renewal plans
The fitness-tracker maker is facing a class action lawsuit alleging it violated California law by failing to provide certain disclosures or obtaining consent before enrolling consumers in its auto-renewal plans. Read More
Read MoreGillette Stadium’s IT provider has opened a tech center in Pawtucket
The official IT and cybersecurity provider for Gillette Stadium has opened a new state-of-the art facility at a Rhode Island business park. Read More
Read MoreNational Grid wins DOE support for major power line across VT, NH
National Grid (NYSE: NGG) has won competitive federal support to build a new transmission line across New Hampshire and Vermont. The high-voltage transmission line would let New England import more Canadian hydropower. Read More
Read MoreSarepta’s Duchenne gene therapy fails to meet main goal in key trial
The Cambridge biotech said late Monday that its gene therapy to treat Duchenne muscular dystrophy failed to meet the primary goal of a large Phase 3 trial, but that it plans to seek full approval regardless. Read More
Read MoreSarepta’s stock plunges after Duchenne gene therapy fails to meet main goal in key trial
The Cambridge biotech’s stock price was cut in half Tuesday morning after it announced late Monday that its gene therapy to treat Duchenne muscular dystrophy failed to meet the primary goal of a large Phase 3 trial. It plans to seek full approval regardless. Read More
Read MoreMass. cannabis businesses sue Merrick Garland over ‘unfair’ federal law
“We want to be treated equally, on an even playing field with any other small business in Massachusetts,” Meg Sanders, CEO and co-founder of Canna Provisions, said. Read More
Read MoreAhead of HQ move, CarGurus has named a new CFO
Ahead of its upcoming move to a new headquarters, automotive shopping site CarGurus has named a new CFO. Read More
Read More